CYCLOPHOSPHAMIDE AND THIOTEPA WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS

被引：52

作者：

EDER, JP

ANTMAN, K

ELIAS, A

SHEA, TC

TEICHER, B

HENNER, WD

SCHRYBER, SM

HOLDEN, S

FINBERG, R

CHRITCHLOW, J

FLAHERTY, M

MICK, R

SCHNIPPER, LE

FREI, E

机构：

[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT MED, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT STAT, BOSTON, MA 02115 USA

[3] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT CANC PHARMACOL, BOSTON, MA 02115 USA

[4] HARVARD UNIV, BETH ISRAEL HOSP,SCH MED,DEPT MED & SURG, DIV MED ONCOL, BOSTON, MA 02215 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 15期

关键词：

D O I：

10.1093/jnci/80.15.1221

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1221 / 1226

页数：6

共 37 条

[1] ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737
[2] ANTMAN K, 1987, CANCER TREAT REP, V71, P119
[3] Antman K, 1987, Important Adv Oncol, P221
[4] BITRAN J, 1988, P ASCO, V7, P46
[5] CHEMICAL STABILITY OF CYCLOPHOSPHAMIDE IN PARENTERAL SOLUTIONS
BROOKE, D
DAVIS, RE
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1973, 30 (02): : 134 - 137
[6] BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233
[7] COHEN BE, 1984, CANCER RES, V44, P4312
[8] COLVIN M, 1982, PHARM PRINCIPLES CAN, P276
[9] HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER
EDER, JP
ANTMAN, K
PETERS, W
HENNER, WD
ELIAS, A
SHEA, T
SCHRYBER, S
ANDERSEN, J
COME, S
SCHNIPPER, L
FREI, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1592 - 1597
[10] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY
FREI, E
CANELLOS, GP
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594